BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02566967-completion@plaintrial.com
DTSTAMP:20261028T233500Z
DTSTART;VALUE=DATE:20180320
SUMMARY:An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve 
 Low Disease Activity (LDA) or Clinical Remission in Patients With Active R
 heumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspe
 ctive — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02566967
URL:https://plaintrial.com/trial/NCT02566967
END:VEVENT
END:VCALENDAR